Understanding PFAS in Pharma: Risks, Regulations, and Readiness

Industry experts Ilaria Coccoglioniti and Joëlle Guittard will offer a concise and practical overview of PFAS - persistent and pervasive chemicals increasingly under regulatory scrutiny. 

Aimed at pharmaceutical professionals, the session will explore the fundamentals of PFAS, recent regulatory trends, and how a risk-based approach can support informed decision-making and compliance planning.

Key Topics:

  • What are PFAS? Understanding their properties, historical use, presence in pharma-related materials, and classification as “forever chemicals”
  • The Regulatory Landscape: Global and EU-level developments, with insights into what might soon impact the pharmaceutical sector
  • Risk-Based Strategy: How to apply PFAS risk assessments to determine the need for testing and regulatory action, supported by recent case examples and screening strategies

Register